COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,286 Articles (22,759 medRxiv, 8,527 bioRxiv)

Most recent first Previous |  Page 803: Articles 8021-8030  | Next

Keeping it close: The role of a Campus COVID Support Team (CCST) in sustaining a safe and healthy university campus during COVID-19
McDonnell, K. A., Castel, A. D., Vyas, A. B., Nagaraj, N. C., Landry, M.
10.1101/2022.05.01.22274540 — Posted: 2022-05-02
Effectiveness of Covid-19 vaccines against SARS-CoV-2 Omicron variant (B.1.1.529): A systematic review with meta-analysis and meta-regression
Pratama, N. R., Wafa, I. A., Budi, D. S., Sutanto, H., Asmarawati, T. P., Wungu, C. D. K.
10.1101/2022.04.29.22274454 — Posted: 2022-05-02
Then and NOW: A Prospective Population-Level Validation of the Abbott ID NOW SARS-CoV-2 Device Implemented in Multiple Settings for Testing Asymptomatic and Symptomatic Individuals
Stokes, W., Venner, A., Buss, E., Tipples, G., Berenger, B.
10.1101/2022.04.30.22274189 — Posted: 2022-05-02
Immunogenicity and safety of the CoronaVac inactivated SARS-CoV-2 vaccine in people with underlying medical conditions: a retrospective study
Li, C., Li, A., Bi, H., Hu, J., Yang, F., Zhou, T., Liang, Y., Su, W., Shi, T., Yang, M., Wang, R., Qin, W., Zhou, Z., Wei, J., Fu, Z., Zhang, Z.
10.1101/2022.04.28.22274402 — Posted: 2022-05-02
Outcomes of convalescent plasma with defined high- versus lower-neutralizing antibody titers against SARS-CoV-2 among hospitalized patients: CoronaVirus Inactivating Plasma (CoVIP), double-blind phase 2 study.
Bartelt, L. A., Markmann, A. J., Nelson, B. G., Keys, J., Root, H., Henderson, H. I., Kuruc, J., Baker, C., Bhowmik, D. R., Hou, Y. J., Premkumar, L., Cornaby, C., Schmitz, J., Weiss, S., Park, Y., Baric, R. S., de Silva, A. M., Lachiewicz, A., Napravnik, S., van Duin, D., Margolis, D. M.
10.1101/2022.04.29.22274387 — Posted: 2022-05-02
Epidemiological and clinical features of SARS-CoV-2 Infection in children during the outbreak of Omicron Variant in Shanghai, March 7-March 31, 2022
Wang, X., Chang, H., Tian, H., Li, J., Wei, Z., Wang, Y., Xia, A., Ge, Y., Wang, J., Liu, G., Cai, J., Wang, J., Zhu, Q., Zhu, Y., Zhai, X., Zeng, M.
10.1101/2022.04.28.22274421 — Posted: 2022-05-02
Evidence for Aerosol Transfer of SARS-CoV2-specific Humoral Immunity
Kedl, R., Hsieh, E., Morrison, T. E., Samayoa-Reyes, G., Flaherty, S., Jackson, C., Rochford, R.
10.1101/2022.04.28.22274443 — Posted: 2022-05-01
Omicron sub-lineages BA.4/BA.5 escape BA.1 infection elicited neutralizing immunity
Khan, K., Karim, F., Ganga, Y., Bernstein, M., Jule, Z., Reedoy, K., Cele, S., Lustig, G., Amoako, D., Wolter, N., Samsunder, N., Sivro, A., San, J. E., Giandhari, J., Tegally, H., Pillay, S., Naidoo, Y., Mazibuko, M., Miya, Y., Ngcobo, N., Manickchund, N., Magula, N., Abdool Karim, Q., von Gottberg, A., Abdool Karim, S., Hanekom, W., Gosnell, B., COMMIT-KZN Team, , Lessells, R., de Oliveira, T., Moosa, Y., Sigal, A.
10.1101/2022.04.29.22274477 — Posted: 2022-05-01
A methodology to generate epidemic scenarios for emerging infectious diseases based on the use of key calendar events
Acuna-Zegarra, M. A., Santana-Cibrian, M., Rodriguez Hernandez-Vela, C. E., Mena, R. H., Velasco-Hernandez, J. X.
10.1101/2022.04.29.22274465 — Posted: 2022-05-01
Healthcare workers' mental health and wellbeing during the COVID-19 pandemic: Longitudinal analysis of interview and social media data
Vera San Juan, N., Martin, S., Badley, A., Maio, L., Gronholm, P., Buck, C., Flores, E., Vanderslott, S., Syversen, A., Mulcahy Symmons, S., Uddin, I., Karia, A., vindrola Padros, C.
10.1101/2022.04.29.22274481 — Posted: 2022-05-01

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).